The opioid crisis in the United States has led to increased hepatitis C virus (HCV) infection among younger populations of people who inject drugs (PWID) and other vulnerable populations, who often seek care at community health centers. Early treatment for HCV can lead to decreased transmission rates and increased cure rates with advances in oral medications. This webinar is Part 1 of a four-part series by the National Nurse-Led Care Consortium (NNCC). During the webinar:
NASTAD will discuss the current landscape of opioid and infectious disease and resources available for health settings to improve screening, testing, and treatment options for patients.
NNCC will review how they started an AmeriCorps State Program to expand opioid outreach and awareness to decrease stigma and provide education about medication-assisted therapy and other resources in Philadelphia, PA.